NPI: 1932477130 · MAYWOOD, NJ 07607 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/02/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 12/02/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,278 | $917K |
| 2019 | 16,127 | $712K |
| 2020 | 17,926 | $682K |
| 2021 | 19,376 | $370K |
| 2022 | 40,143 | $334K |
| 2023 | 26,267 | $336K |
| 2024 | 9,073 | $443K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 51,450 | 3,195 | $3.02M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,958 | 1,692 | $302K |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,630 | 1,390 | $270K |
| A4657 | Syringe, with or without needle, each | 7,191 | 2,436 | $37K |
| J1756 | Injection, iron sucrose, 1 mg | 9,687 | 1,607 | $27K |
| 83970 | 2,681 | 1,536 | $23K | |
| 85041 | 3,085 | 1,858 | $22K | |
| 85048 | 3,066 | 1,846 | $22K | |
| 83540 | 2,034 | 1,202 | $20K | |
| 83550 | 1,364 | 1,037 | $20K | |
| 82728 | 1,916 | 1,149 | $19K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 205 | 24 | $13K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,530 | 482 | $2K |
| OP250 | 10,974 | 247 | $108.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,053 | 378 | $8.20 |
| G0008 | Administration of influenza virus vaccine | 212 | 131 | $4.75 |
| 90662 | 54 | 24 | $0.00 | |
| 90674 | 87 | 54 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 13 | 13 | $0.00 |